Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) - Schedule of computation of diluted income (loss) per share

v3.22.2.2
Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) - Schedule of computation of diluted income (loss) per share - shares
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 14,827,991 4,301,215
Warrants to purchase common stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 63,000 63,000
Options to purchase common stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 12,000
Unvested restricted stock units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,286,701 4,224,016
Unvested restricted stock awards [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 12,478,290
Convertible Series B preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,199